BIOMAT Database Logo BIOMAT Database Logo

Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. 1970

Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa

UI MeSH Term Description Entries
D007933 Leucomycins An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D008034 Lincomycin An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincolnensin,Lincomycin, (2S-cis)-Isomer,Epilincomycin,Lincocin,Lincomycin A,Lincomycin Hydrochloride,Lincomycin Monohydrochloride,Lincomycin Monohydrochloride, (2S-cis)-Isomer,Lincomycin Monohydrochloride, (L-threo)-Isomer,Lincomycin Monohydrochloride, Hemihydrate,Lincomycin, (L-threo)-Isomer,Hemihydrate Lincomycin Monohydrochloride
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009174 Mycoplasma A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS. Eperythrozoon,Haemobartonella,Mycoplasma putrefaciens,PPLO,Pleuropneumonia-Like Organisms,Pleuropneumonia Like Organisms
D009175 Mycoplasma Infections Infections with species of the genus MYCOPLASMA. Eperythrozoonosis,Infections, Mycoplasma,Eperythrozoonoses,Infection, Mycoplasma,Mycoplasma Infection
D009827 Oleandomycin Antibiotic macrolide produced by Streptomyces antibioticus. Oleandomycin Phosphate,Phosphate, Oleandomycin
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat

Related Publications

Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae.
May 1974, Antimicrobial agents and chemotherapy,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
April 2011, Future microbiology,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
[Resistance of Mycoplasma pneumoniae to macrolides antibiotics].
March 2005, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
December 1979, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
Drug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics.
January 2014, BioMed research international,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
[Acute pancreatitis, erythromycin and Mycoplasma pneumoniae infection].
March 1991, Medicina clinica,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin.
January 1989, Diagnostic microbiology and infectious disease,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
[Resistance to erythromycin in Streptococcus pneumoniae].
December 1991, Enfermedades infecciosas y microbiologia clinica,
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
Resistance of Mycoplasma pneumoniae to erythromycin: a clinical case with severe pulmonary, cerebral and systemic complications.
July 1989, Journal of chemotherapy (Florence, Italy),
Y Niitu, and S Hasegawa, and T Suetake, and H Kubota, and S Komatsu, and M Horikawa
Erythromycin and other macrolide antibiotics.
January 1982, Giornale italiano di chemioterapia,
Copied contents to your clipboard!